About: Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by Henri J Huttunen et al published 15 August 2002 in Cancer Research

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2002 (uk) article scientifique publié en 2002 (fr) im August 2002 veröffentlichter wissenschaftlicher Artikel (de) article by Henri J Huttunen et al published 15 August 2002 in Cancer Research (en)
publication date	wds:Q57909992-55F18A86-F748-41B3-A0F0-5414981B3F2F
publication date	2002-08-15 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57909992-EEEA8134-1308-4C83-942D-F32F072CE322
language of work or name	English
author name string	wds:Q57909992-2FA57CFC-593B-4D06-8F87-22A0258B75C1 wds:Q57909992-31C49488-ECBA-42E3-821A-8E5FE2AD3C07 wds:Q57909992-6E7CECCE-067B-40F3-8E79-A0F38F7EC3CE wds:Q57909992-DD8223CD-DE8C-4902-B72C-E836C085A2DE
author name string	Heikki Rauvala Juha Kuja-Panula Henri J Huttunen Carole Fages
rdfs:label	Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis (en) Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis (nl)
skos:prefLabel	Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis (en) Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis (nl)
name	Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis (en) Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis (nl)
author	wds:Q57909992-5793C125-8980-4FD0-8F16-63DFE57E7613
author	Anne Ridley
title	wds:Q57909992-B50716E0-ACD0-4660-AC01-CE96967294AA
title	Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis (en)
page(s)	wds:Q57909992-99AC1DF3-F778-45E9-8EC1-86D91EDD390F
page(s)	4805-11
instance of	wds:Q57909992-CAFCD497-8970-43C8-9EFF-5B24C179DD47
instance of	scholarly article
PubMed ID	wds:Q57909992-1F990DCF-F877-4001-96B0-C163D2287147
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12183440
PubMed ID	12183440
published in	wds:Q57909992-41A37687-4104-4C87-9BDB-1E422444697D
published in	Cancer Research
issue	wds:Q57909992-21A733F1-01E7-4047-A6C4-49746ACD4C49
volume	wds:Q57909992-2049EE14-9F98-4636-920A-0E0BF62986A5
issue	16
volume	62
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57909992
is cites work of	RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis Potential role of high mobility group box 1 in viral infectious diseases High-mobility group box 1, oxidative stress, and disease HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth. Plasma HMGB-1 Levels in Subjects with Obesity and Type 2 Diabetes: A Cross-Sectional Study in China S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE) The G82S polymorphism promotes glycosylation of the receptor for advanced glycation end products (RAGE) at asparagine 81: comparison of wild-type rage with the G82S polymorphic variant. Mitochondrial transcription factor A, an endogenous danger signal, promotes TNFα release via RAGE- and TLR9-responsive plasmacytoid dendritic cells Association of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting Understanding RAGE, the receptor for advanced glycation end products Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis Tissue-specific expression patterns of the RAGE receptor and its soluble forms—a result of regulated alternative splicing? Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer High-mobility group box 1: an amplifier of stem and progenitor cell activity after stroke Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival HMGB1 is a therapeutic target for sterile inflammation and infection HMGB1 in cancer: good, bad, or both? Targeting HMGB1 in inflammation The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction High-mobility group protein box-1 and its relevance to cerebral ischemia Novel HMGB1-inhibiting therapeutic agents for experimental sepsis The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases Single proteins might have dual but related functions in intracellular and extracellular microenvironments Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain Potentiation of NMDA receptor-dependent cell responses by extracellular high mobility group box 1 protein HMGB1 in health and disease Identification of a functional interaction of HMGB1 with Receptor for Advanced Glycation End-products in a model of neuropathic pain. HMGB1 increases permeability of the endothelial cell monolayer via RAGE and Src family tyrosine kinase pathways Relationship between high-mobility group box 1 overexpression in ovarian cancer tissue and serum: a meta-analysis HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review Role of HMGB1 in cardiovascular diseases Emerging role of high-mobility group box 1 (HMGB1) in liver diseases High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation Therapeutic potential of HMGB1-targeting agents in sepsis Hemorrhagic shock activation of NLRP3 inflammasome in lung endothelial cells Carboxylated N-glycans on RAGE promote S100A12 binding and signaling Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal p High-mobility group box 1 protein initiates postoperative cognitive decline by engaging bone marrow-derived macrophages Interacting neuroendocrine and innate and acquired immune pathways regulate neutrophil mobilization from bone marrow following hemorrhagic shock Hemorrhagic shock activates lung endothelial reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase via neutrophil NADPH oxidase HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells. Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients DAMPs, ageing, and cancer: The 'DAMP Hypothesis'. Life after death: targeting high mobility group box 1 in emergent cancer therapies The C-terminal acidic tail is responsible for the inhibitory effects of HMGB1 on efferocytosis. Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases Effect of dietary advanced glycation end products on mouse liver The association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice Low molecular weight heparin suppresses receptor for advanced glycation end products-mediated expression of malignant phenotype in human fibrosarcoma cells. Emerging role of HMGB1 in lung diseases: friend or foe. Ousting RAGE in melanoma: A viable therapeutic target? High mobility group B1 and N1 (HMGB1 and HMGN1) are associated with tumor-infiltrating lymphocytes in HER2-positive breast cancers.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software